ArticleNPJ precision oncology2025
Deep learning for automated, motion-resolved tumor segmentation in radiotherapy.
Article in NPJ precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The impact of AI on modern oncology from early detection to personalized cancer treatment.NPJ precision oncology · 2026Review
- Applications of artificial intelligence in non-small cell lung cancer: from precision diagnosis to personalized prognosis and therapy.Journal of translational medicine · 2025Review
- Artificial Intelligence and Machine Learning in Lung Cancer: Advances in Imaging, Detection, and Prognosis.Cancers · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate tumor delineation is foundational to radiotherapy. In the era of deep learning, the automation of this labor-intensive and variation-prone process is increasingly tractable. We developed a deep neural network model to segment gross tumor volumes (GTVs) in the lung and propagate them across 4D CT images to generate an internal target volume (ITV), capturing tumor motion during respiration. Using a multicenter cohort-based registry from 9 clinics across 2 health systems, we trained a 3D UNet model (iSeg) on pre-treatment CT images and corresponding GTV masks (n = 739, 5-fold cross-validation) and validated it on two independent cohorts (n = 161; n = 102). The internal cohort achieved a median Dice (DSC) of 0.73 [IQR: 0.62-0.80], with comparable performance in external cohorts (DSC = 0.70 [0.52-0.78] and 0.71 [0.59-79]), indicating multi-site validation. iSeg matched human inter-observer variability and was robust to image quality and tumor motion (DSC = 0.77 [0.68-0.86]). Machine-generated ITVs were significantly smaller than physician delineated contours (p < 0.0001), indicating more precise delineation. Notably, higher false positive voxel rate (regions segmented by the machine but not the human) were associated with increased local failure (HR: 1.01 per voxel, p = 0.03), suggesting the clinical relevance of these discordant regions. These results mark a leap in automated target volume segmentation and suggest that machine delineation can enhance the accuracy, reproducibility, and efficiency of this core task in radiotherapy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.